Navigating The Oligometastatic Frontier:
Strategies for Adaptation and Personalized Management
Saturday, May 4 from 13:00 to 14:00
Location: Room Boisdale
Moderators:
Vincent Khoo, M.D., Consultant in Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK
Seth Blacksburg, M.D., MBA, Senior Vice President, Chief Medical Officer, Accuray
Saturday May 4 from 13:00 to 14:00
Location: Room Boisdale
Moderators:
Vincent Khoo, M.D., Consultant in Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK
Seth Blacksburg, M.D., MBA, Senior Vice President, Chief Medical Officer, Accuray
Navigating the Evolving Oligometastatic Paradigm: Clinical, Pathological, and Radiographic Adaptations
Piet Ost, M.D., Ph.D., Associate Professor at Ghent University, Ghent and Radiation Oncologist at the Iridium Network, Antwerp, Belgium
Stereotactic Body Radiation Therapy for Oligometastatic Disease: Benefits and Limitations
Nicholas van As, M.D., Medical Director and Consultant Clinical Oncologist of The Royal Marsden NHS Foundation Trust and Professor in Precision Prostate Radiotherapy at The Institute of Cancer Research, London, UK
Integration of Systemic and Targeted Therapies in the Management of Oligometastatic SBRT
Barbara Jereczek-Fossa, M.D., Ph.D., Full Professor of Radiation Oncology at Department of Oncology and Hemato-oncology at the University of Milan, and Head of the Department of Radiation Oncology at the European Institute of Oncology IRCCS (IEO), Milan, Italy
Oligometastatic Disease: State of the Art
Umberto Ricardi, M.D., Full Professor of Radiation Oncology and Chairman of the Radiation Oncology Department, University of Turin, Turin, Italy
